Rossi, Alessandra
Orecchioni, Stefania
Falvo, Paolo
Tabanelli, Valentina
Baiardi, Elena http://orcid.org/0000-0002-5432-4751
Agostinelli, Claudio
Melle, Federica
Motta, Giovanna
Calleri, Angelica
Fiori, Stefano
Corsini, Chiara
Casadei, Beatrice
Mazzara, Saveria
Vitolo, Umberto http://orcid.org/0000-0001-7772-2747
Bertolini, Francesco
Zinzani, Pier Luigi http://orcid.org/0000-0002-2112-2651
Alcalay, Myriam
Pelicci, Pier Giuseppe
Pileri, Stefano
Tarella, Corrado http://orcid.org/0000-0003-1473-6046
Derenzini, Enrico http://orcid.org/0000-0002-7154-8140
Article History
Received: 1 November 2020
Revised: 28 June 2021
Accepted: 8 July 2021
First Online: 24 July 2021
Competing interests
: AR, SO, PF, VT, EB, CA, FM, GM, AC, SF, CC, BC, SM, MA: nothing to disclose; UV: Consulting or advisory role for Celgene, Janssen, Genmab, Incyte, Bristol-Myers Squibb; speakers’ bureau with Roche, Celgene, Janssen, Gilead Sciences, Sandoz, Abbvie; research funding from Roche and Celgene; research funding from Roche and Celgene. FB: research funding, Gilead Sciences, Menarini, Emercell. PLZ: speakers’ bureau or advisory boards for Verastem, Celltrion, Gilead, Janssen-cilag, Bristol-Myers Squibb, Servier, Sandoz, MSD, Immune Design, Celgene, Portola, Roche, Eusapharma, Kyowa Kirin, Sanofi. PGP: member of advisory commette BRIC Copenaghen, MD Anderson Cancer Center, Houston (Tx). SP: Advisory Boards for Celgene, NanoString, Roche. CT: advisory board, ADC- Therapeutics. ED: research funding from TG-Therapeutics, ADC-Therapeutics, Takeda; Advisory board for Gilead, Astra Zeneca, Takeda.